Company overview
Basic information
Company name
NORAMEDA, UAB
Company code
140744584
VAT code
LT407445811
Registered address
Vilnius, Meistrų g. 8A, LT-02190
Registration date
1993-09-02
Company age: 33 y.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Website
https://www.norameda.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Wholesale of pharmaceutical and medical goods
Ownership form
Privately owned with foreign capital
Uždaroji akcinė bendrovė "NORAMEDA"
Company code: 140744584
Address: Vilnius, Meistrų g. 8A, LT-02190
VAT code: LT407445811
Download a detailed company report
Make confident decisions with all the information about NORAMEDA, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
NORAMEDA, UAB (company code 140744584) is an operational private limited liability company registered in 1993. It operates in the sector of national private non-financial companies and is classified as private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and capital from foreign investors included. The company is managed by a CEO only and is described as medium-sized. Its registered address is Meistru g. 8A, Vilnius, Vilniaus m. sav., Vilniaus apskr. The company’s activity is EVRK G.46.46.00, wholesale of pharmaceutical and medical goods. In the latest financial year shown in the data, revenue increased from €28.37M in 2023 to €31.28M in 2024. Net profit remained broadly stable at about €829K, while the profit margin edged down from 2.9% to 2.7%. At the end of 2024, equity stood at €6.63M, liabilities at €7.52M, and total assets at €14.12M. Staffing has been stable at 35 average employees in 2023-2025, before easing to 34 so far in 2026. Average monthly wage increased from €5,067.28 in 2023 to €5,780.38 in 2025, and stood at €5,720.52 so far in 2026.